Old Mission Capital LLC Mesoblast LTD Transaction History

Old Mission Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.73 - $3.7 $136,368 - $184,822	49,952 New	49,952 $145,000
Q4 2019 Feb 14, 2020	SELL	$5.74 - $7.42 $170,202 - $220,017	-29,652 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.68 - $7.42 $138,771 - $220,017	29,652 New	29,652 $205,000
Q1 2019 May 14, 2019	SELL	$4.19 - $5.25 $60,951 - $76,371	-14,547 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.51 - $8.6 $51,059 - $125,104	14,547 New	14,547 $60,000
Q2 2018 Aug 14, 2018	SELL	$5.27 - $6.21 $88,841 - $104,688	-16,858 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.91 - $7.72 $82,772 - $130,143	16,858 New	16,858 $97,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.